Cite Filings / ALGS / 0000950170-23-058256

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Aligos Therapeutics, Inc. Filed 2023-11-02 Acc 0000950170-23-058256

Documents 1

10-Q Quarterly Report , algs-20230930.htm

Around this filing

2024-05-07 10-Q Quarterly Report
2023-11-07 D Notice of Sales of Unregistered Securities
2023-11-06 SC 13D Beneficial Ownership Report
2023-11-02 SC 13G Amended Statement of Ownership
2023-11-02 8-K Results of operations
2023-11-02 10-Q Quarterly Report
2023-08-03 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading algs-20230930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…